Sepideh Dashti

635 total citations
27 papers, 462 citations indexed

About

Sepideh Dashti is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Sepideh Dashti has authored 27 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Sepideh Dashti's work include Cancer-related molecular mechanisms research (16 papers), RNA Research and Splicing (9 papers) and RNA modifications and cancer (7 papers). Sepideh Dashti is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), RNA Research and Splicing (9 papers) and RNA modifications and cancer (7 papers). Sepideh Dashti collaborates with scholars based in Iran, Iraq and Poland. Sepideh Dashti's co-authors include Soudeh Ghafouri‐Fard, Mohammad Taheri, Majid Kheirollahi, Bashdar Mahmud Hussen, Mir Davood Omrani, Parvin Mahzouni, Zahra Khalaj, Maryam Derakhshan, Ali Zekri and Abbasali Keshtkar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Cellular Physiology.

In The Last Decade

Sepideh Dashti

27 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sepideh Dashti Iran 15 315 292 46 44 36 27 462
Tingting Chen China 14 341 1.1× 252 0.9× 35 0.8× 100 2.3× 63 1.8× 38 523
Chunliang Shang China 14 379 1.2× 357 1.2× 74 1.6× 102 2.3× 63 1.8× 30 607
Ghim Siong Ow Singapore 12 352 1.1× 216 0.7× 19 0.4× 55 1.3× 68 1.9× 16 482
Yincheng Teng China 13 319 1.0× 199 0.7× 81 1.8× 102 2.3× 71 2.0× 38 534
Jimin Guo Canada 9 411 1.3× 207 0.7× 45 1.0× 70 1.6× 18 0.5× 13 504
Lihua Ding China 11 314 1.0× 167 0.6× 35 0.8× 81 1.8× 35 1.0× 20 406
Xihu Qin China 13 309 1.0× 228 0.8× 52 1.1× 56 1.3× 60 1.7× 32 448
Ahmed E. Elesawy Egypt 11 290 0.9× 304 1.0× 24 0.5× 56 1.3× 22 0.6× 19 429

Countries citing papers authored by Sepideh Dashti

Since Specialization
Citations

This map shows the geographic impact of Sepideh Dashti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sepideh Dashti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sepideh Dashti more than expected).

Fields of papers citing papers by Sepideh Dashti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sepideh Dashti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sepideh Dashti. The network helps show where Sepideh Dashti may publish in the future.

Co-authorship network of co-authors of Sepideh Dashti

This figure shows the co-authorship network connecting the top 25 collaborators of Sepideh Dashti. A scholar is included among the top collaborators of Sepideh Dashti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sepideh Dashti. Sepideh Dashti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghafouri‐Fard, Soudeh, et al.. (2021). BCYRN1: An oncogenic lncRNA in diverse cancers. Pathology - Research and Practice. 220. 153385–153385. 15 indexed citations
2.
Ghafouri‐Fard, Soudeh, et al.. (2021). X-Inactive-Specific Transcript: Review of Its Functions in the Carcinogenesis. Frontiers in Cell and Developmental Biology. 9. 690522–690522. 14 indexed citations
3.
Ghafouri‐Fard, Soudeh, et al.. (2021). A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies. Biomedicine & Pharmacotherapy. 137. 111366–111366. 24 indexed citations
4.
Ghafouri‐Fard, Soudeh, Hamed Shoorei, Sepideh Dashti, Wojciech Branicki, & Mohammad Taheri. (2020). Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response. Journal of Cellular Physiology. 235(12). 9269–9290. 17 indexed citations
5.
Ghafouri‐Fard, Soudeh, et al.. (2020). Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. Experimental and Molecular Pathology. 114. 104415–104415. 12 indexed citations
6.
Dashti, Sepideh, Mohammad Taheri, & Soudeh Ghafouri‐Fard. (2020). An in-silico method leads to recognition of hub genes and crucial pathways in survival of patients with breast cancer. Scientific Reports. 10(1). 18770–18770. 24 indexed citations
7.
Ghafouri‐Fard, Soudeh, Sepideh Dashti, Mohammad Taheri, & Mir Davood Omrani. (2020). TINCR: An lncRNA with dual functions in the carcinogenesis process. Non-coding RNA Research. 5(3). 109–115. 29 indexed citations
8.
Dashti, Sepideh, et al.. (2020). Expression analysis of growth arrest specific 8 and its anti-sense in breast cancer tissues. Experimental and Molecular Pathology. 114. 104414–104414. 2 indexed citations
9.
Ghafouri‐Fard, Soudeh, Sepideh Dashti, & Mohammad Taheri. (2020). PCAT1: An oncogenic lncRNA in diverse cancers and a putative therapeutic target. Experimental and Molecular Pathology. 114. 104429–104429. 17 indexed citations
10.
Ghafouri‐Fard, Soudeh, et al.. (2020). Deleted in lymphocytic leukemia 2 (DLEU2): An lncRNA with dissimilar roles in different cancers. Biomedicine & Pharmacotherapy. 133. 111093–111093. 14 indexed citations
11.
Ghafouri‐Fard, Soudeh, et al.. (2020). HOX transcript antisense RNA: An oncogenic lncRNA in diverse malignancies. Experimental and Molecular Pathology. 118. 104578–104578. 19 indexed citations
12.
Ghafouri‐Fard, Soudeh, et al.. (2020). Expression analysis of vimentin and the related lncRNA network in breast cancer. Experimental and Molecular Pathology. 115. 104439–104439. 27 indexed citations
13.
Dashti, Sepideh, et al.. (2020). In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples. Scientific Reports. 10(1). 8316–8316. 24 indexed citations
14.
Taheri, Mohammad, et al.. (2019). Assessment of the expression pattern of mTOR‐associated lncRNAs and their genomic variants in the patients with breast cancer. Journal of Cellular Physiology. 234(12). 22044–22056. 20 indexed citations
15.
Dashti, Sepideh, et al.. (2019). Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies. BMC Medical Genetics. 20(1). 79–79. 14 indexed citations
16.
Dashti, Sepideh, et al.. (2019). Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer. Experimental and Molecular Pathology. 112. 104359–104359. 10 indexed citations
17.
Dashti, Sepideh, et al.. (2019). Cellular immune responses against cancer-germline genes in cancers. Human Antibodies. 28(1). 57–64. 2 indexed citations
18.
Dashti, Sepideh, et al.. (2018). Expression of brain-derived neurotrophic factor (BDNF) and its naturally occurring antisense in breast cancer samples. Meta Gene. 19. 69–73. 8 indexed citations
19.
Sichani, Mehrdad Mohammadi, et al.. (2015). Mutation analysis of SLC3A1 and SLC7A9 genes in patients with cystinuria. Urolithiasis. 43(5). 447–453. 11 indexed citations
20.
Kheirollahi, Majid, et al.. (2014). Brain tumors: Special characters for research and banking. SHILAP Revista de lepidopterología. 4(1). 4–4. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026